Tuberculosis (TB), derived from bacterium named Mycobacterium tuberculosis, has become
one of the worst infectious and contagious illnesses in the world after HIV/AIDS. Long-term …

The treatment and management of tuberculosis using conventional drug delivery systems
remain challenging due to the setbacks involved. The lengthy and costly treatment regime …

Metal-organic frameworks (MOFs) are a highly versatile class of ordered porous materials,
which hold great promise for different biomedical applications, including antibacterial …

Toxoplasma gondii and Mycobacterium tuberculosis are pathogens that are harmful to
humans. When these diseases interact in humans, the result is typically fatal to the public …

Tuberculosis (TB), caused by Mycobacterium tuberculosis, continues to pose a significant
threat to global health. The resilience of TB is amplified by a myriad of physical, biological …

Tuberculosis (TB) is currently the second deadliest infectious disease. Existing
antitubercular therapies are long, complex, and have severe side effects that result in low …

This study explored the development of novel biomimetic tannic acid–based hybrid
nanocarriers (HNs) for targeted delivery of ciprofloxacin (CIP-loaded TAH-NPs) against …

The massive use and abuse of antibiotics has given birth to drug-resistant bacteria and
emergence of severe bacterial infections in people. Intriguingly, light activated antimicrobial …

Tuberculosis remains one of the major health problems worldwide. Besides the lungs,
tuberculosis affects other organs, including bones and joints. In the case of bone …

The effective delivery of poor water-soluble anti-tubercular drugs such as isoniazid to their
target sites is a major factor that has made it difficult for tuberculosis to be eradicated …